Acetylshikonin induces apoptosis through the endoplasmic reticulum stress‐activated PERK/eIF 2α /CHOP axis in oesophageal squamous cell carcinoma
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Ya-Jiao Yuan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, College of Clinical and Basic Medicine, Shandong First Medical University & Shandong academy of med…. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Anthraquinones. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Health Science and Technology Project of Shandong Provincial Health Commission, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Acetylshikonin (AS) is an active component of Lithospermum erythrorhizon Sieb. et Zucc that exhibits activity against various cancers; however, the underlying mechanisms of AS against oesophageal squamous carcinoma (ESCC) need to be elusive. The research explores the anti‐cancer role and potential mechanism of AS on ESCC in vitro and in vivo, providing evidences for AS treatment against ESCC. In this study, we firstly demonstrated that AS treatment effectively inhibits cell viability and proliferation of ESCC cells. In addition, AS significantly induces G1/S phage arrest and promotes apoptosis in ESCC cell lines. Further studies reveal that AS induces ER stress, as observed by dose‐ and time‐dependently increased expression of BIP, PDI, PERK, phosphorylation of eIF 2α , CHOP and splicing of XBP1. CHOP knockdown or PERK inhibition markedly rescue cell apoptosis induced by AS. Moreover, AS treatment significantly inhibits ESCC xenograft growth in nude mice. Elevated expression of BIP and CHOP is also observed in xenograft tumours. Taken together, AS inhibits proliferation and induces apoptosis through ER stress‐activated PERK/eIF 2α /CHOP pathway in ESCC, which indicates AS represents a promising candidate for ESCC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, College of Clinical and Basic Medicine, Shandong First Medical University & Shandong academy of medical sciences, Jinan, China.
- Department of Clinical Laboratory, Qingdao Jimo People's Hospital, Qingdao, China.
- Department of Clinical Laboratory, Taian Central Hospital, China.
ORCID-Profile: Jian-Ling Xu, Beibei Sun
Förderung
- Medical Health Science and Technology Project of Shandong Provincial Health Commission
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Shandong First Medical University
Zitieren
APA
Yuan, Y. J., Liu, S., Yang, H., Xu, J. L., Zhai, J., Jiang, H. M., & Sun, B. (2024). Acetylshikonin induces apoptosis through the endoplasmic reticulum stress‐activated PERK/eIF 2α /CHOP axis in oesophageal squamous cell carcinoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18030
Vancouver
Yuan YJ, Liu S, Yang H, Xu JL, Zhai J, Jiang HM, et al. Acetylshikonin induces apoptosis through the endoplasmic reticulum stress‐activated PERK/eIF 2α /CHOP axis in oesophageal squamous cell carcinoma. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18030
BibTeX
@article{Yuan2024,
author = {Yuan, Ya-Jiao and Liu, Shanshan and Yang, Hong and Xu, Jian-Ling and Zhai, Jing and Jiang, Han-Ming and Sun, Beibei},
title = {Acetylshikonin induces apoptosis through the endoplasmic reticulum stress‐activated PERK/eIF 2α /CHOP axis in oesophageal squamous cell carcinoma},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18030}
}
EUVIMED